Table 4.
Clinical studies with antidiabetic and antihyperlipidemic essential oils.
Disease | Authors | Type of clinical study | Number of patients | Treatment | Results |
---|---|---|---|---|---|
Diabetes mellitus | Jafari et al., 2017 | Randomized, control study | 99 type 2 DM patients with suboptimal glycemic control | Cumin essential oil 50 and 100 mg/day for 8 weeks | Reduction of fasting blood glucose and glycosylated hemoglobin (HbA1C) |
Diabetes mellitus | Bilal et al., 2009 | Randomized control study | 41 type 2 DM patients | Black cumin essential oil 700 mg/day for 40 days | Reduction of fasting blood glucose |
Diabetes mellitus | Jafari et al., 2017 | Randomized control study | 64 prediabetic patients | Cumin essential oil 75 mg/day for 10 weeks | No significant change in glycemic indices; significant improvement of lipid profile |
Diabetes mellitus, Dyslipidemia | Keihan et al., 2016 | Randomized control study | 95 diabetic and dyslipidemic patients | Cumin essential oil 25 mg/day for 90 days | Reduction of fasting blood glucose, HbA1C, triglycerides and oxidized LDL |
Dyslipidemia | Hadi et al., 2018 | Meta-analysis | 6 RCTs with 376 patients | Cumin essential oil | Significant reduction of total cholesterol and LDL |
Metabolic syndrome | Morovati et al., 2019 | Randomized control study | 56 patients with metabolic syndrome | Cumin essential oil 75 mg t.i.d. for 8 weeks | Reduction of fasting blood glucose and total cholesterol |